Obtaining Information to Understand and Challenges and Opportunities Encountered by Compounding Outsourcing Facilities

Forms and Documents

Document	Type	Status	Availability
0910-0883_Supplemental Document-Analysis of Proposed Questions_2-25-2026.docx	Supplementary Document	Uploaded 2026-02-27	Repair queued
0910-0883_Supporting Statement A_2025_Revised_02-25-2026.docx	Supporting Statement A	Uploaded 2026-02-27	Repair queued
0883_Supporting Statement A_2025.docx	Supporting Statement A	Uploaded 2025-05-02	Repair queued
Pharmaceutical Research and Manufacturers of America PhRMA Commnt.pdf	Public Comments	Uploaded 2025-05-02	Repair queued
OUTSOURCING FACILITIES ASSOCIATION Comment.pdf	Public Comments	Uploaded 2025-05-01	Repair queued
Novo Nordisk Inc Comment.pdf	Public Comments	Uploaded 2025-05-01	Repair queued
Medisca Comment.pdf	Public Comments	Uploaded 2025-05-01	Repair queued
0883_Supporting Statement_B_2025.docx	Supporting Statement B	Uploaded 2025-05-01	Repair queued
0883_Supporting Statement_B_2025.docx	Supporting Statement B	Uploaded 2025-05-01	Repair queued

IC Document Collections

IC ID	Collection	Type	Status	Form
239201	Compounding Outsourcing Facilities Survey	Other-Survey Instrument	Modified

ICR Details

OMB Control No: 0910-0883	ICR Reference No: 202505-0910-001
Status: Active	Previous ICR Reference No: 202302-0910-007
Agency/Subagency: HHS/FDA	Agency Tracking No: CDER
Title: Obtaining Information to Understand and Challenges and Opportunities Encountered by Compounding Outsourcing Facilities
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 03/03/2026
Retrieve Notice of Action (NOA)	Date Received in OIRA: 06/18/2025
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	03/31/2029	36 Months From Approved	03/31/2026
Responses	250	0	600
Time Burden (Hours)	146	0	600
Cost Burden (Dollars)	0	0	0

---

Abstract: FDA seeks to engage in research to analyze and better understand perspectives on challenges and opportunities faced by outsourcing facilities as they attempt to supply safe, high-quality drug products needed by patients. The Agency currently lacks this information and cannot obtain it from other sources. An electronic survey will be administered to approximately 80 outsourcing facilities to gather information regarding the challenges an opportunities these entities face. The results of this research will be used by FDA to develop a comprehensive understanding of the outsourcing facility sector, its challenges, and opportunities for advancement. The information will be essential to help identify knowledge and information gaps, operational barriers, and views on interactions with FDA. The research results will inform FDA's future approaches to communication, education, training, and other engagement with outsourcing facilities to address challenges and support advancement of the industry in its ability to produce high-quality drug products that are safe for patients.

---

Authorizing Statute(s): US Code: 21 USC 353 Name of Law: Federal Food, Drug, and Cosmetic Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	89 FR 72410	09/05/2024
30-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 18663	05/01/2025
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Compounding Outsourcing Facilities Survey

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	250	600	0	0	-350	0
Annual Time Burden (Hours)	146	600	0	0	-454	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: Our estimated burden for the information collection reflects an overall decrease of 454 hours and a corresponding decrease of 350 responses. We revised the survey to improve clarity and simplify the experience for participants. We made grammatical, stylistic, format, and other editorial changes to the content. In doing so, we reduced the number of questions from 31 to 20. We anticipate a reduction in burden hours to 30 minutes (.50 hour) per survey response from our previous estimate of 1 hour per response.

---

Annual Cost to Federal Government: $11,850

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 05/02/2025

---